HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Kadri Altundag Selected Research
Kadri Altundag Research Topics
Disease
234
Breast Neoplasms (Breast Cancer)
05/2024 - 12/2003
68
Neoplasms (Cancer)
01/2023 - 01/2004
42
Neoplasm Metastasis (Metastasis)
01/2021 - 01/2004
22
Triple Negative Breast Neoplasms
04/2024 - 01/2008
10
Brain Neoplasms (Brain Tumor)
01/2021 - 02/2005
9
Multiple Myeloma
07/2021 - 01/2005
9
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2007 - 04/2004
8
Obesity
04/2017 - 01/2005
7
Osteonecrosis (Kienbock's Disease)
07/2021 - 06/2006
7
Cardiotoxicity
12/2017 - 12/2012
7
Osteoporosis
01/2016 - 12/2005
6
Noninfiltrating Intraductal Carcinoma (DCIS)
12/2023 - 07/2005
6
Arthralgia (Joint Pain)
03/2020 - 12/2007
4
Calcinosis
01/2021 - 01/2006
4
Glioblastoma (Glioblastoma Multiforme)
01/2018 - 01/2005
4
Colorectal Neoplasms (Colorectal Cancer)
01/2014 - 11/2003
3
Pathologic Complete Response
03/2020 - 11/2017
3
Ductal Carcinoma
01/2019 - 05/2016
3
Lymphedema (Milroy Disease)
01/2018 - 01/2017
3
Overweight
04/2017 - 06/2013
3
Adenocarcinoma
01/2017 - 06/2005
3
Lymphoma (Lymphomas)
01/2015 - 04/2004
3
Nasopharyngeal Carcinoma
01/2012 - 01/2004
3
Lung Neoplasms (Lung Cancer)
01/2007 - 08/2004
3
Head and Neck Neoplasms (Head and Neck Cancer)
01/2007 - 01/2005
2
Lobular Carcinoma
05/2020 - 01/2019
2
Residual Neoplasm
09/2019 - 01/2007
2
Contracture
11/2018 - 11/2005
2
Alopecia (Baldness)
04/2017 - 01/2016
Drug/Important Bio-Agent (IBA)
48
Hormones (Hormone)
IBA
05/2024 - 01/2004
37
Trastuzumab (Herceptin)
FDA Link
09/2021 - 01/2004
25
Aromatase Inhibitors
IBA
07/2020 - 10/2004
20
Estrogen Receptors
IBA
01/2022 - 01/2004
19
Tamoxifen
FDA Link
Generic
05/2024 - 12/2003
15
Paclitaxel (Taxol)
FDA Link
Generic
05/2021 - 07/2004
14
Diphosphonates (Bisphosphonates)
IBA
11/2017 - 01/2004
13
Capecitabine (Xeloda)
FDA Link
05/2024 - 11/2011
13
taxane
IBA
01/2023 - 01/2005
12
Zoledronic Acid (Zometa)
FDA Link
07/2021 - 01/2004
12
Progesterone Receptors (Progesterone Receptor)
IBA
09/2020 - 01/2004
12
Phenobarbital (Luminal)
FDA Link
09/2020 - 04/2009
12
Estrogens (Estrogen)
FDA Link
07/2020 - 01/2004
12
ErbB Receptors (EGF Receptor)
IBA
11/2019 - 06/2005
11
Anthracyclines
IBA
05/2021 - 01/2005
10
Cyclophosphamide (Cytoxan)
FDA Link
Generic
10/2022 - 01/2005
9
Vitamin D
FDA Link
Generic
03/2019 - 01/2004
8
human ERBB2 protein
IBA
09/2021 - 01/2005
7
eribulin
FDA Link
10/2023 - 09/2015
7
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2018 - 01/2004
7
Fluorouracil (Carac)
FDA Link
Generic
07/2007 - 11/2003
6
Vinorelbine (Navelbine)
FDA Link
Generic
10/2022 - 04/2014
6
pertuzumab
IBA
09/2021 - 10/2012
5
C-Reactive Protein
IBA
12/2023 - 02/2005
5
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
09/2021 - 12/2011
5
Letrozole (Femara)
FDA Link
Generic
03/2020 - 12/2003
5
Lapatinib (GW572016)
FDA Link
01/2017 - 05/2010
4
Ado-Trastuzumab Emtansine
IBA
09/2021 - 04/2013
4
Taxoids (Taxanes)
IBA
05/2021 - 12/2008
4
Docetaxel (Taxotere)
FDA Link
05/2021 - 04/2014
4
Calcifying Nanoparticles
IBA
01/2021 - 01/2005
4
Progesterone
FDA Link
Generic
07/2020 - 04/2008
4
Blood Group Antigens (Blood Groups)
IBA
07/2018 - 06/2013
4
Biomarkers (Surrogate Marker)
IBA
05/2017 - 04/2008
4
Androgens
IBA
01/2016 - 01/2005
4
Proteins (Proteins, Gene)
FDA Link
01/2015 - 01/2004
4
Monoclonal Antibodies
IBA
08/2013 - 01/2004
4
Cisplatin (Platino)
FDA Link
Generic
01/2007 - 01/2004
3
olaparib
IBA
11/2023 - 01/2015
3
Pentoxifylline (Trental)
FDA Link
Generic
01/2023 - 01/2006
3
Proton Pump Inhibitors
IBA
01/2022 - 01/2017
3
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
11/2018 - 01/2004
3
exemestane (Aromasin)
FDA Link
01/2015 - 10/2004
3
Epirubicin (Ellence)
FDA Link
Generic
04/2014 - 01/2005
3
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
02/2014 - 01/2006
3
Cadherins (E-Cadherin)
IBA
07/2012 - 01/2004
3
Pamidronate (Aredia)
FDA Link
Generic
06/2008 - 01/2004
3
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
04/2008 - 01/2005
3
Imatinib Mesylate (Gleevec)
FDA Link
11/2005 - 01/2005
2
Interleukin-6 (Interleukin 6)
IBA
10/2023 - 02/2005
2
Cardiotoxins
IBA
01/2023 - 03/2011
2
palbociclib
IBA
01/2022 - 01/2022
2
Anti-Bacterial Agents (Antibiotics)
IBA
09/2019 - 03/2003
2
Tumor Biomarkers (Tumor Markers)
IBA
07/2019 - 04/2008
2
Tyrosine Kinase Inhibitors
IBA
01/2019 - 12/2012
2
Androgen Receptors (Androgen Receptor)
IBA
09/2018 - 09/2012
2
Dexamethasone (Maxidex)
FDA Link
Generic
01/2018 - 09/2004
2
Selective Estrogen Receptor Modulators (SERM)
IBA
08/2017 - 01/2006
Therapy/Procedure
52
Therapeutics
01/2022 - 01/2004
47
Drug Therapy (Chemotherapy)
04/2024 - 01/2004
23
Neoadjuvant Therapy
05/2021 - 02/2005
21
Radiotherapy
01/2023 - 01/2004
11
Adjuvant Chemotherapy
03/2021 - 12/2005
3
Mastectomy (Mammectomy)
01/2019 - 01/2017
3
Breast Implants (Breast Implant)
11/2018 - 11/2005
3
Duration of Therapy
01/2016 - 12/2014
3
Chemoradiotherapy
01/2015 - 01/2005
2
Adjuvant Radiotherapy
11/2018 - 09/2015
2
Sutures (Suture)
01/2018 - 01/2017
2
Mammaplasty (Breast Reconstruction)
01/2018 - 02/2006
2
Combination Drug Therapy (Combination Chemotherapy)
04/2017 - 01/2012